Forex
HomeForex
Timely, reliable coverage of breaking news, insights, and analyses on Stocks and Forex.
Piramal Enterprises (PEL) Stock Plummets 6% After Q4 Results, Marks 10.4% Weekly Decline
Piramal Enterprises, a leading diversified non-banking financial company (NBFC), saw a 6.15% drop in its shares in today's intraday trade, following the release...
Beyond Meat (BYND) Plummets as Vital Farms (VITL) Soars, Highlighting Shift in Food Investment Trends
Two food producers, Beyond Meat and Vital Farms, reported contrasting quarterly results, causing their stocks to move in opposite directions.
While Beyond Meat...
Indian Stock Market’s Unprecedented 5-Day Decline: Analyzing the Impact on Cryptocurrency Coins and Symbols
The Indian stock market continues its downward trend for the fifth consecutive session on Thursday, May 9, with the Nifty 50 index and...
AI Demand Skyrockets S&P 500 REIT xScale Portfolio Value, Surpasses $8 Billion Mark
Data center landlord Equinix (EQIX) leads the S&P 500 after surpassing earnings forecasts with strong AI and cloud demand.
Equinix reported a 3.1%...
Analyzing BSE Stock’s Unpredictable Shifts Post-Q4 Results: Expert Insights on the Multibagger Coin (BSE)
BSE share price experiences volatility in Thursday's trading session following the announcement of its Q4 results.
The stock exchange reported a 70% increase in revenue...
Tesla (TSLA) Shares Plunge 30% in 2024, While Rival Automaker Soars 40% with Robust Q1 EV Growth
School bus manufacturer Blue Bird (BLBD) has reported a significant rise in its fiscal second-quarter earnings, setting a new record for electric school...
Jupiter Wagons (JW) Skyrockets 10% to Record High Following Stellar Q4 Results
Jupiter Wagons shares hit a record high following a significant increase in net profit for Q4FY24.
The company's standalone net profit surged 155...
Neurocrine (NBIX) Outshines Competitors with Stellar Performance in 2024: A Comprehensive Financial Analysis
Neurocrine Biosciences (NBIX) is diversifying from its blockbuster drug Ingrezza, with several promising developments this year.
The biotech stock has climbed roughly 7%...